Louise M. Murphy, PhD, MBA, CQA
Louise M. Murphy, PhD, MBA, CQA is President and CEO and a founder of ClinDatrix. As such, she directed the company’s development from its inception and remains responsible for all of its activities. Most of the members of the executive team report directly to her, and she plays an active quality assurance/quality control role in all of the company’s client projects. She also consults on data management and clinical services.
Dr. Murphy has more than 30 years of experience in research, 26 of them in the pharmaceutical, biotechnology and CRO industries. Her most recent position outside of ClinDatrix was to serve as Senior Vice President, Global Clinical Research for Allergan’s medical device division for three years. While there, she was responsible for the functional areas of clinical research and operations, biostatistics, data management and medical writing. She designed and executed approximately 20 trials to obtain and/or maintain the CE mark in Europe or U.S. approval under an IDE or PMA. One project was a 56,000-patient study at 1,500 U.S. and Canadian sites using electronic data capture.
Dr. Murphy previously was Vice President, Clinical Informatics at ICON Clinical Research. There she was responsible for the startup of the Irvine office and for U.S. data management services. Prior to joining ICON, Dr. Murphy served as Vice President, Clinical Informatics at CoCensys, Inc., a biotechnology company. At CoCensys, she was responsible for data management, biostatistics, clinical and statistical programming, medical writing and drug safety. She also oversaw the clinical development program for stroke. Previously she held positions with CRO firms and was responsible for the functions of data management, programming and biostatistics. Prior to her association with these companies, Dr. Murphy held the position of Acting Director, Biostatistics at Allergan, Inc.A founding Director of the Society for Clinical Data Management, Dr. Murphy also has held various positions within the PMA Clinical Data Management focus. (PMA, or the Pharmaceutical Management Association, has since become the Pharmaceutical Research and Manufacturers of America or PhRMA.) Dr. Murphy has conducted courses in clinical data management internationally. She holds Masters and Doctorate Degrees in Experimental Medicine from McGill University, Montreal, Canada. While at McGill, she conducted research in cardiovascular mechanics and in respiratory physiology. Dr. Murphy also obtained an executive MBA from the University of California, Irvine, and recently earned her Certified Quality Auditor (CQA) certification from the American Society for Quality.